Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Valacyclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Glioblastoma 3 Epstein-Barr Virus Infections 3 Lung Neoplasms 2 Leukemia 2 Glioma 2 Cytomegalovirus Infections 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Stomatitis 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Melanoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Infectious Mononucleosis 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 579 130-nm albumin-bound paclitaxel 164 Fluorouracil 159 Oxaliplatin 142 Albumin-Bound Paclitaxel 129 Leucovorin 111 Capecitabine 109 Irinotecan 94 Radiotherapy 83 Taxes 72 pembrolizumab 70 Cisplatin 66 Erlotinib Hydrochloride 61 Radiosurgery 60 Nivolumab 45 Bevacizumab 45 Cyclophosphamide 44 Magnetic Resonance Spectroscopy 43 Drug Therapy 41 Docetaxel 37 Specimen Handling 35 Cetuximab 35 folfirinox 33 irinotecan sucrosofate 32 S 1 (combination) 31 Biopsy 30 Pancreaticoduodenectomy 28 Blood Specimen Collection 28 Paclitaxel 27 Radiation 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡